Press Releases

Lifeasible Supports a Comprehensive Range of Environmental Tests

Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.

CsPbX3 Perovskite Nanocrystals Are Now Available at Creative Diagnostics

Quantum dots have long been a focus of researches on photovoltaic devices, biosensors and catalysis and as a global supplier with experienced technical teams, Creative Diagnostics introduces CsPbX3 Perovskite Nanocrystals for various applications.

CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

As a top-class institution as well as experienced supplier in drug delivery, CD Bioparticles now launches cover-all PEG conjugations to global clients.

Latest Updates: CAR Design and Construction Services Are Optimized at Creative Biolabs

Based on the leading CellRapeuticsTM CAR technology platform, Creative Biolabs has optimized the CAR design and construction services, especially for CAR-T therapy and CAR-NK therapy.

ERT Expands eCOA Solution for Higher Fidelity CNS Assessments

Partnership with Cogstate delivers digital cognitive assessments to improve the speed and effectiveness of clinical trials

TrialScope Welcomes Moderna into Its Community of Clinical Trial Sponsors

TrialScope, the global leader in clinical trial disclosure and transparency management technology, adds Moderna to its growing customer roster.

Alfa Chemistry Optimized Precious Metal Catalysts Recovery and Refining Service

Alfa Chemistry announced earlier this month that it has taken measures to optimize metal catalysts recovery and refining service.

Noxopharm Reports Idronoxil Achieves Major Industry Goal of Converting ‘Cold’ Tumors to ‘Hot’

Noxopharm, a clinical-stage Australian oncology drug development company listed on the ASX (ASX:NOX), has claimed a breakthrough in the search for restoring immune function within “cold” microtumors, converting them to so-called “hot” tumors.

Life Sciences Industry Accelerates Growth and Navigates COVID-19 with eClinical Solutions’ ASCEND Clinical Data Services

Boston pharma tech innovator supports faster clinical trials and regulatory drug approvals with advanced technology platforms and statistical expertise

ERT Leader Recognized by PharmaVoice for Delivering Innovation in Clinical Trial Imaging

Enhanced solution improves data accuracy to increase respiratory clinical trial efficiencies

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products.

BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens

Specimens can be used to validate SARS-CoV-2 in-vitro diagnostics, develop new drugs and vaccines, and investigate the impact of co-morbidities and social demographics on disease progression

Michael Gibertini Joins Elligo as Chief Development Officer

Elligo Health Research is proud to welcome Michael Gibertini, Ph.D., to its leadership team. Gibertini joins the team at the healthcare-enabling company as the new chief development officer and will develop new lines of business to support Elligo’s mission to bring clinical research as a care option to patients.

CluePoints Launches Powerful Business Intelligence Platform

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new business intelligence platform, BEYOND. Designed to encompass more than just early risk detection, this extended visualization solution takes CluePoints beyond the interrogation of data and allows Sponsor and CRO users to explore areas of interest in one integrated business intelligence system.

snapIoT Announces AI-Powered Automated IRB Packaging and UAT Reporting for Patient Engagement Solutions

snapIoT announces a new feature for it's snapClinical platform - IRB Packaging and UAT Reporting. This feature was designed to automate and expedite the submission process of patient engagement solutions for IRB and ethics approvals which allows Pharmas and CROs to quickly deploy decentralized trials in a faster and more reliable manner.

Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry

Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

Broad-spectrum Antiviral Drug Discovery Services Are Ready to Facilitate SARS-CoV-2 Research

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Genome Researchers and Projects